SEC Form 4 research
| Issuer | Alzamend Neuro, Inc. |
|---|---|
| Tickers | ALZN |
| Reporting owners | 14 |
| Officers and directors | 5 |
| Last public filing | 2026-09-01 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-31 | 2026-08-26 | AULT MILTON C III | S | 2,000 | $1.56 | Not reported |
| 2026-08-31 | 2026-04-14 | AULT MILTON C III | P | 2,000 | $1.03 | Not reported |
| 2026-08-31 | 2026-04-14 | AULT MILTON C III | P | 108,388 | $1 | Not reported |
| 2026-08-31 | 2026-04-14 | AULT MILTON C III | P | 2,000 | $1.03 | Not reported |
| 2026-08-31 | 2026-04-14 | AULT MILTON C III | P | 108,388 | $1 | Not reported |
| 2026-08-20 | 2026-07-31 | Ault Capital Group, Inc., Ault Lending, LLC, Hyperscale Data, Inc. | A | 7,500 | $1,000 | Not reported |
| 2026-08-04 | 2026-07-31 | Hyperscale Data, Inc. | A | 7,500 | $1,000 | Not reported |
| 2026-08-04 | 2026-07-31 | AULT MILTON C III | A | 7,500 | $1,000 | Not reported |
| 2026-08-04 | 2026-04-17 | Nisser Henry Carl | A | 60,000 | $0 | Not reported |
| 2026-08-04 | 2026-04-17 | AULT MILTON C III | A | 100,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.